Learn more about using CBD to treat opioid addiction
Updated: Aug 9, 2019
What are opioids and why are they so dangerously addictive?
Opioids refer to a broad and potent group of pain-relieving drugs, which work by binding to the opioid receptors in the brain blocking pain signals sent from the body to the brain.
In fact, the U.S. declared opioid addiction a full-blown public health emergency in 2017.
Opioid dependence is a disease that affects the brain creating a physical and a psychological need for the drug. Opioid withdrawal can cause painful physical symptoms including nausea, vomiting, diarrhea, hot and cold sweats, and extreme anxiety to name a few.
CBD (Cannabidiol) is one of the cannabinoids in marijuana. CBD has been shown to be non-psycho active in delivering the health benefits of marijuana without the intoxication. Studies show that when CBD is administered to opioid addicts, cravings diminish allowing people to rehabilitate naturally and painlessly.
At Scripps Research Institute in San Diego, researchers gave alcohol and cocaine to rats who subsequently developed addictive behavior. The researchers then applied a gel containing CBD once per day for a week to the skin of the rats in their study. Tests were performed to see how they reacted to stress and anxiety-causing situations and behavior and tests of impulsiveness which is associated with drug addiction.
The researchers reported that CBD effectively reduced relapse incited by stress and drug cues. CBD also reduced anxiety and impulsivity in the substance addicted rats revealing startling evidence that CBD could obliterate opioid addiction entirely.
In further studies, it was shown that even though the CBD was completely gone from the rats’ brains and plasma after three days, unexpectedly five months later the formerly addicted rats still showed reduced relapse when presented with stress or drug cues. This could open new vistas for treating and preventing drug relapse.
CBD is available in many forms: gel, capsule, oil, spray, cream, gummies, and many more.
For more information ask your medical professional or visit our website at www.cannabismedicalnetwork.com
About the Author
Philip M. Cohen is CEO of CMN Holdings, Inc. and their subsidiaries, Cannabis Medical Network, a digital media network airing in cannabis doctors waiting rooms and Cannabis Lifestyle Network, airing in dispensary waiting rooms. Phil has operated a dozen ad-supported digital signage networks in doctor offices and at retail since 1985 and is a past Chairman of the Digital Signage Federation.